Yazar "Baysak, Sevim" için listeleme
-
Clinical and demographic features of hidradenitis suppurativa: A multicentre study of 1221 patients with an analysis of risk factors associated with disease severity
Özkur, Ezgi; Karadağ, Ayşe Serap; Üstüner, P.; Aksoy, Bülent; Esme, Pelin; Çalışkan, E.; Akoğlu, Gülşen; Kalkan, Gülhan; Demirseren, Duriye Deniz; Polat, Mualla; Özden, Müge Güler; Kılınç, Fadime; Yalçınkaya İyidal, Ayşegül; Kıvanç Altunay, İlknur; Türkmen, Meltem; Uğurer, Ece; Baysak, Sevim; Fettahlıoğlu Karaman, Bilge; Mammadli, Kifayat; Baykal Selçuk, Leyla; Türkoğlu, Zülal; Atçı, Tolgahan; Didar Balcı, Didem; Özsoy Adışen, Esra; Temel, Berkay; Aktan, Serhat; Gelincik Kaçar, Nida; Gündüz, Kamer; Türel Ermertcan, Aylin; Özdemir, Mustafa; Ünal Çakıter, Alkım; Çölgeçen, Emine; Uçmak, Derya; Kelekçi, Handan Kıymet; Ataseven, Arzu; Durmaz, Koray; Kaya Özden, Hatice; Engin, Berat; Özbek Yazıcı, Sercan; Alpsoy, Erkan (Wiley, 2021)Background Hidradenitis suppurativa (HS) is a chronic, relapsing and debilitating inflammatory disease associated with profound morbidity. Aim In this multicentre study, we investigated the demographic and clinical ... -
Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: Real-world data from a retrospective multicenter study
Topal, İlteriş Oğuz; Baysak, Sevim; Kıvanç Altunay, İlknur; Kara Polat, Asude; Arıkan, Eylem Emel; Özkur, Ezgi; Aytekin, Sema; Doğan, Bilal; Özkök Akbulut, Tuğba; Topaloğlu Demir, Filiz; Karadağ, Ayşe Serap (Elsevier Science Inc, 2022)Background: Clinical studies have demonstrated that IL-17A inhibition with secukinumab is effective for clearing the skin of patients with psoriasis and has a favorable safety profile. Objective: The authors aim to determine ...